| VYVGART |
VYVGART |
90%
|
We also have distribution agreements in place with several distribution partners for VYVGART |
| AGMB |
AGMB |
72%
|
Reciprocal relationship from AGMB graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from AGMB graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from AGMB g… |
| AGMB |
AGMB |
72%
|
rrently generating product net sales on a straight-line basis over the estimated useful life, being the longer of the current patent protection life of the acquired R&D and patent protection life of … |
| AZN |
AstraZeneca PLC |
72%
|
Reciprocal relationship from AZN graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from AZN graph: Reciprocal relationship from ARGX graph: more than 26 years of experience in q… |
| AZN |
AstraZeneca PLC |
72%
|
more than 26 years of experience in quality assurance within the pharmaceutical industry. Most recently, Ms. Wilk served as senior director, head of medical, regulatory & clinical quality assurance a… |
| IMVT |
Immunovant, Inc. |
72%
|
Reciprocal relationship from IMVT graph: gulated, unapproved and off-label treatments. Even if a biosimilar product is less effective than our product candidates, a less effective biosimilar may be m… |
| JNJ |
Johnson & Johnson |
72%
|
lement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more fully below. These risks include, among othe… |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from ARGX graph: lement our business strategy is subject to numerous risks that you should be aware of before making an investment deci… |
| MS-PE |
Morgan Stanley |
72%
|
Reciprocal relationship from MS-PE graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from MS-PE graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from MS-P… |
| MS-PK |
Morgan Stanley |
72%
|
estors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting tho… |
| NVSEF |
Novartis AG |
72%
|
lement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more fully below. These risks include, among othe… |
| NVSEF |
Novartis AG |
72%
|
Reciprocal relationship from NVSEF graph: Reciprocal relationship from ARGX graph: lement our business strategy is subject to numerous risks that you should be aware of before making an investment de… |
| ABBVIE-INC-AMGEN-INC-BIOGEN-INC |
ABBVIE-INC-AMGEN-INC-BIOGEN-INC |
62%
|
lement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more fully below. These risks include, among othe… |
| ASTELLAS-PHARMA-INC |
ASTELLAS-PHARMA-INC |
62%
|
more than 26 years of experience in quality assurance within the pharmaceutical industry. Most recently, Ms. Wilk served as senior director, head of medical, regulatory & clinical quality assurance a… |
| CO-LLC |
CO-LLC |
62%
|
estors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting tho… |
| CO-LLC-BOFA-SECURITIES-INC |
CO-LLC-BOFA-SECURITIES-INC |
62%
|
estors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting tho… |
| COMPANY-LLC |
COMPANY-LLC |
62%
|
estors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting tho… |
| F-HOFFMAN-LA-ROCHE-AG |
F-HOFFMAN-LA-ROCHE-AG |
62%
|
lement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more fully below. These risks include, among othe… |
| HEALTH-RESOURCES |
HEALTH-RESOURCES |
62%
|
o more than an established discounted price for its covered outpatient drugs. The formula for determining the discounted price is defined by statute and is based on the AMP and the unit rebate amount… |
| JOHNSON-INNOVATION-INC |
JOHNSON-INNOVATION-INC |
62%
|
lement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more fully below. These risks include, among othe… |
| J-P-MORGAN-SECURITIES-LLC |
J-P-MORGAN-SECURITIES-LLC |
62%
|
estors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting tho… |
| PEER-GROUP |
PEER-GROUP |
62%
|
ricted share units in an amount that is at or around the 50th percentile of the U.S. companies in our reference group. Per 2021, we granted 2,700 stock options and 600 RSUs to each Non-Executive Dire… |
| REFERENCE-PEER-GROUP |
REFERENCE-PEER-GROUP |
62%
|
ricted share units in an amount that is at or around the 50th percentile of the U.S. companies in our reference group. Per 2021, we granted 2,700 stock options and 600 RSUs to each Non-Executive Dire… |
